North Star Investment Management’s Nektar Therapeutics NKTR Stock Holding History

North Star Investment Management’s Portfolio NKTR Stock Details NKTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-8	Closed	-$72	–	1293
2023 Q2	$72	Hold	8	–	–	﹤0.01%	1273
2023 Q1	$88	Hold	8	–	–	﹤0.01%	1282
2022 Q4	$282	Hold	8	–	–	﹤0.01%	1264
2022 Q3	$0	Hold	8	–	–	﹤0.01%	1165
2022 Q2	$0	Hold	8	–	–	﹤0.01%	1163
2022 Q1	$1K	Hold	8	–	–	﹤0.01%	1108
2021 Q4	$2K	Hold	8	–	–	﹤0.01%	1085
2021 Q3	$2K	Hold	8	–	–	﹤0.01%	1040
2021 Q2	$2K	Hold	8	–	–	﹤0.01%	1020
2021 Q1	$2K	Hold	8	–	–	﹤0.01%	977
2020 Q4	$2K	Hold	8	–	–	﹤0.01%	958
2020 Q3	$2K	Hold	8	–	–	﹤0.01%	936
2020 Q2	$3K	Hold	8	–	–	﹤0.01%	877
2020 Q1	$2K	Hold	8	–	–	﹤0.01%	923
2019 Q4	$3K	Hold	8	–	–	﹤0.01%	968
2019 Q3	$2K	Buy	+8	New	+$2.93K	﹤0.01%	1012
2019 Q2	–	Sell	-5	Closed	-$3K	–	731
2019 Q1	$3K	Hold	5	–	–	﹤0.01%	978
2018 Q4	$2K	Buy	5 +2	+67%	+$1.21K	﹤0.01%	988
2018 Q3	$3K	Buy	+3	New	+$2.56K	﹤0.01%	994

Other funds holding NKTR

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return

North Star Investment Management's NKTR Position: Q3 2023 in Review

North Star Investment Management sold out of Nektar Therapeutics (NKTR) in Q3 2023, closing a stake of 8 shares — an estimated $72 sold.

North Star Investment Management first reported a position in NKTR in Q3 2018 and held it in 19 quarters. The position peaked at $3K in Q2 2020. 138 funds tracked by Wall St. Rank hold NKTR as of Q3 2023.

North Star Investment Management reported no remaining Nektar Therapeutics position as of Q3 2023 after selling out during the quarter.
North Star Investment Management sold 8 Nektar Therapeutics shares in Q3 2023, an estimated $72.
North Star Investment Management first reported a position in Nektar Therapeutics in Q3 2018 and held it in 19 quarters.
North Star Investment Management's Nektar Therapeutics position peaked at $3K in Q2 2020.
138 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q3 2023.

Based on North Star Investment Management's 13F filing for Q3 2023, filed 6 Nov 2023.